Palisade Bio (PALI) Receivables - Other (2016 - 2023)

Palisade Bio (PALI) posted quarterly Receivables - Other of $105625.0 for Q4 2023, down 25.22% year-over-year from $141250.0 in Q4 2022, and little changed quarter-over-quarter from $105625.0 in Q3 2023.

Palisade Bio (PALI) Receivables - Other (2016 - 2023) Analysis & Trends

Palisade Bio (PALI) has reported Receivables - Other for 7 consecutive years, with $105625.0 the latest figure, recorded in Q4 2023.

  • In Q4 2023, Receivables - Other fell 25.22% year-over-year to $105625.0; the TTM figure through Dec 2023 stood at $105625.0 (down 25.22% YoY), while the FY2023 annual figure was $105625.0, down 25.22% from the prior year.
  • Receivables - Other held at $105625.0 in Q4 2023 per PALI's latest filing, from $105625.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $229000.0 in Q1 2019 and bottomed at $105625.0 in Q2 2023.
  • Historically, Receivables - Other has averaged $187375.0 across 4 years, with a median of $229000.0 in 2019.
  • Annual changes were most pronounced in 2019 — Receivables - Other jumped 267.88% — and 2023, when it slipped 25.22%.
  • Palisade Bio's Receivables - Other stood at $229000.0 in 2019, then changed by 0.0% to $229000.0 in 2020, then slumped by 38.32% to $141250.0 in 2022, then slipped by 25.22% to $105625.0 in 2023.
  • Business Quant data shows PALI's Receivables - Other at $105625.0 in Q4 2023, $105625.0 in Q3 2023, and $105625.0 in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Palisade Bio 372.94 Mn 247.74 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 105,625.00
Dec 31, 2023 105,625.00
Sep 30, 2023 105,625.00
Sep 30, 2023 105,625.00
Jun 30, 2023 105,625.00
Jun 30, 2023 105,625.00
Dec 31, 2022 141,250.00
Dec 31, 2022 141,250.00
Dec 31, 2020 229,000.00
Dec 31, 2020 229,000.00
Sep 30, 2020 229,000.00
Sep 30, 2020 229,000.00
Jun 30, 2020 229,000.00
Jun 30, 2020 229,000.00
Mar 31, 2020 229,000.00
Mar 31, 2020 229,000.00
Sep 30, 2019 229,000.00
Sep 30, 2019 229,000.00
Jun 30, 2019 229,000.00
Jun 30, 2019 229,000.00